denkapparat Operations’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Other funds holding APLS
denkapparat Operations's APLS Position: Q2 2026 in Review
denkapparat Operations sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 13,334 shares — an estimated $536K sold.
denkapparat Operations first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $536K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- denkapparat Operations reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- denkapparat Operations sold 13,334 Apellis Pharmaceuticals shares in Q2 2026, an estimated $536K.
- denkapparat Operations first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
- denkapparat Operations's Apellis Pharmaceuticals position peaked at $536K in Q1 2026.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.